This articlerelies largely or entirely on asingle source. Relevant discussion may be found on thetalk page. Please helpimprove this article byintroducing citations to additional sources. Find sources: "Tynorphin" – news ·newspapers ·books ·scholar ·JSTOR(November 2014) |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C35H46N6O7 |
| Molar mass | 662.788 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tynorphin is asyntheticopioid peptide which is apotent andcompetitiveinhibitor of theenkephalinase class ofenzymes which break down theendogenousenkephalinpeptides.[1] It specifically inactivatesdipeptidyl aminopeptidase III (DPP3) with very highefficacy, but also inhibitsneutral endopeptidase (NEP),aminopeptidase N (APN), andangiotensin-converting enzyme (ACE) to a lesser extent.[1] It has apentapeptidestructure with theamino acid sequence Val-Val-Tyr-Pro-Trp (VVYPW).
Tynorphin was discovered in an attempt to develop an enkephalinase inhibitor of greater potency thanspinorphin.[1]